Nav: Home

Know thy enemy: Kill MRSA with tailored chemistry

December 22, 2016

UConn medicinal chemists have developed experimental antibiotics that kill MRSA, a common and often deadly bacteria that causes skin, lung, and heart infections. The success is due to their strategy, which found a weakness and exploited it in a way the bacteria should have trouble countering, the researchers report in the Dec. 22 issue of Cell Chemical Biology.

Cases of MRSA (Methicillin-Resistant Staphylococcus aureus) are on the rise and increasingly resistant to common antibiotics. The first choice treatment for MRSA, trimethoprim-sulfamethoxazole, is relatively safe and inexpensive. But trimethoprim-resistant MRSA has begun to spread around the globe. Up to 30% of infections in sub-Saharan African no longer respond to it, and significant numbers in Europe and Asia as well. UConn medicinal chemists Amy Anderson, Dennis Wright and Ph.D. student Stephanie Reeve have been working to develop a drug that will be harder for MRSA to evolve resistance against. They had several candidates in the works when they asked colleagues at UConn Health and Hartford Hospital to start collecting trimethoprim-resistant strains of MRSA as test cases.

"Although resistance [to trimethoprim] in the community is generally less than 10% in our local area, resistance elsewhere is climbing. Additionally, many vulnerable patient populations cannot take trimethoprim-sulfamethoxazole or other generic drugs because of side effects they may cause, and new agents are needed," says Dr. Michael Nailor, a UConn pharmacologist co-funded with Hartford Hospital.

The local samples showed just how fast antibiotic resistance is spreading. Six of nine bacterial strains collected had genes for trimethoprim resistance that had never before been seen in the US. The strains were also variously resistant to other antibiotics such as erythromycin and tetracycline.

But they didn't stand a chance against the experimental antibiotics from Anderson, Wright and Reeve's lab.

"We've actually taken strains [of MRSA] from the clinic and shown our compounds work. We were really happy about these results," says Stephanie Reeve. Their strategy had worked.

"One of the most exciting aspect of this work was that we had worked hard to design broadly acting inhibitors against many different resistant forms of the enzymes and these designs proved very effective against two new enzymes we had never considered or previously studied," says Wright. The strategic approach the chemists had taken was to target the bacteria's use of Vitamin B9. Also known as folate, it's as critical to MRSA bacteria as it is to us. Block its action and a vital enzyme pathway is shut down. The bacteria die. Trimethoprim is currently the only antibacterial antifolate available, and bacteria have evolved different versions of the folate enzyme that aren't impaired by it. But Anderson, Wright and Reeve thought they should be able to make other, better antifolates. They painstakingly analyzed the molecular structure of the enzyme they were up against, and exactly how it needed to interact with other molecules to do its job. Only by understanding its form and function could they foil versions of the enzyme they'd never seen before, Wright says.

Armed with their knowledge, they designed new antifolates. These drugs are crafted to bind the enzyme in such a way that if the enzyme changes enough to evade them, it won't be able to do its job with vitamin B9, either. That will hopefully make it harder for bacteria to evolve resistance. The drugs' success against the trimethoprim-resistant strains of MRSA sampled so far bodes well.

The team is now gathering more MRSA from across the country. Dr. Jeffrey Aeschlimann, a UConn Health associate professor of pharmacy practice says, "We'd like to determine if the resistance mechanisms we discovered in our local MRSA strains are also found in other clinics throughout the United States. We also may find other novel resistance mechanisms. In both cases, we will be able to gain even more valuable information about our how our new antibiotics work against MRSA."
-end-


University of Connecticut

Related Bacteria Articles:

How bacteria fertilize soya
Soya and clover have their very own fertiliser factories in their roots, where bacteria manufacture ammonium, which is crucial for plant growth.
Bacteria might help other bacteria to tolerate antibiotics better
A new paper by the Dynamical Systems Biology lab at UPF shows that the response by bacteria to antibiotics may depend on other species of bacteria they live with, in such a way that some bacteria may make others more tolerant to antibiotics.
Two-faced bacteria
The gut microbiome, which is a collection of numerous beneficial bacteria species, is key to our overall well-being and good health.
Microcensus in bacteria
Bacillus subtilis can determine proportions of different groups within a mixed population.
Right beneath the skin we all have the same bacteria
In the dermis skin layer, the same bacteria are found across age and gender.
Bacteria must be 'stressed out' to divide
Bacterial cell division is controlled by both enzymatic activity and mechanical forces, which work together to control its timing and location, a new study from EPFL finds.
How bees live with bacteria
More than 90 percent of all bee species are not organized in colonies, but fight their way through life alone.
The bacteria building your baby
Australian researchers have laid to rest a longstanding controversy: is the womb sterile?
Hopping bacteria
Scientists have long known that key models of bacterial movement in real-world conditions are flawed.
Bacteria uses viral weapon against other bacteria
Bacterial cells use both a virus -- traditionally thought to be an enemy -- and a prehistoric viral protein to kill other bacteria that competes with it for food according to an international team of researchers who believe this has potential implications for future infectious disease treatment.
More Bacteria News and Bacteria Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Making Amends
What makes a true apology? What does it mean to make amends for past mistakes? This hour, TED speakers explore how repairing the wrongs of the past is the first step toward healing for the future. Guests include historian and preservationist Brent Leggs, law professor Martha Minow, librarian Dawn Wacek, and playwright V (formerly Eve Ensler).
Now Playing: Science for the People

#566 Is Your Gut Leaking?
This week we're busting the human gut wide open with Dr. Alessio Fasano from the Center for Celiac Research and Treatment at Massachusetts General Hospital. Join host Anika Hazra for our discussion separating fact from fiction on the controversial topic of leaky gut syndrome. We cover everything from what causes a leaky gut to interpreting the results of a gut microbiome test! Related links: Center for Celiac Research and Treatment website and their YouTube channel
Now Playing: Radiolab

The Flag and the Fury
How do you actually make change in the world? For 126 years, Mississippi has had the Confederate battle flag on their state flag, and they were the last state in the nation where that emblem remained "officially" flying.  A few days ago, that flag came down. A few days before that, it coming down would have seemed impossible. We dive into the story behind this de-flagging: a journey involving a clash of histories, designs, families, and even cheerleading. This show is a collaboration with OSM Audio. Kiese Laymon's memoir Heavy is here. And the Hospitality Flag webpage is here.